Concepedia
2
Publications
63
Citations
H-Index
1981
Active since
Affiliations
Sanofi (France)(Current)
Samuel Adelman is an author at Sanofi (France).
Publications per year
1981–2024
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim Papp et al. · Journal of Allergy and Clinical Immunology · 2024 · 34 citations · Full text
Pityriasis rosea
Larry D. Hudson, Samuel Adelman, Charles Lewis · Journal of the American Academy of Dermatology · 1981 · 29 citations
Rows per page
1–2 of 2